Classification Term: 170968

Hepoxilins (ontology term: 59c5494af0e56ce9816c7514f716e65c)

found 12 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Ancestor: Eicosanoids

Child Taxonomies: There is no child term of current ontology term.

11,12-DiHETrE

(+/-)-11,12-dihydroxy-5Z,8Z,14Z,17Z-eicosatetraenoic acid

C20H34O4 (338.24569640000004)


11,12-DiHETrE is a Cytochrome P450 (P450) eicosanoid. Arachidonic acid may be oxygenated by cytochrome P450 in several ways. Epoxidation of the double bonds leads to the regio- and enantioselective formation of four epoxyeicosatrienoic acids (EETs), which are hydrolyzed by epoxide hydrolase to vicinal diols (DHETs). 11,12-DiHETrE excretion is increased in healthy pregnant women compared with nonpregnant female volunteers, and increased even further in patients with pregnancy-induced hypertension (PIH). The physiological significance of arachidonic acid epoxides has been debated and it is unknown whether they play a role in pregnancy and parturition. Vasodilative effects, inhibition of cyclooxygenase, or inhibition of platelet aggregation by EETs have been observed only at micromolar concentrations. On the other hand, effects on the stimulus-secretion coupling during hormone release have been found in the nanomolar and picomolar range. (PMID: 9440131, 2198572) [HMDB] 11,12-DiHETrE is a Cytochrome P450 (P450) eicosanoid. Arachidonic acid may be oxygenated by cytochrome P450 in several ways. Epoxidation of the double bonds leads to the regio- and enantioselective formation of four epoxyeicosatrienoic acids (EETs), which are hydrolyzed by epoxide hydrolase to vicinal diols (DHETs). 11,12-DiHETrE excretion is increased in healthy pregnant women compared with nonpregnant female volunteers, and increased even further in patients with pregnancy-induced hypertension (PIH). The physiological significance of arachidonic acid epoxides has been debated and it is unknown whether they play a role in pregnancy and parturition. Vasodilative effects, inhibition of cyclooxygenase, or inhibition of platelet aggregation by EETs have been observed only at micromolar concentrations. On the other hand, effects on the stimulus-secretion coupling during hormone release have been found in the nanomolar and picomolar range. (PMID: 9440131, 2198572).

   

Hepoxilin B3

(5Z,8Z)-10-hydroxy-10-[(2R,3S)-3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoic acid

C20H32O4 (336.2300472)


Hepoxilin B3 is a normal human epidermis eicosanoid. Hepoxilin B3 is dramatically elevated in psoriatic lesions. The primary biological action of the hepoxilins appears to relate to their ability to release calcium from intracellular stores through a receptor-mediated action. The receptor is intracellular, and appears to be G-protein coupled. The conversion of hepoxilin into its omega-hydroxy catabolite has recently been demonstrated through the action of an omega-hydroxylase. This enzyme is different from that which oxidizes leukotriene B4, as the former activity is lost when the cell is disrupted, while leukotriene B4-catabolic activity is recovered in both the intact and disrupted cell. Additionally, hepoxilin catabolism is inhibited by CCCP, a mitochondrial uncoupler, while leukotriene catabolism is unaffected. As hepoxilins cause the translocation of calcium from intracellular stores in the endoplasmic reticulum to the mitochondria, it is speculated that hepoxilin omega-oxidation takes place in the mitochondria, and the omega-oxidation product facilitates accumulation of the elevated cytosolic calcium by the mitochondria. (PMID 10692117, 11851887, 10086189) [HMDB] Hepoxilin B3 is a normal human epidermis eicosanoid. Hepoxilin B3 is dramatically elevated in psoriatic lesions. The primary biological action of the hepoxilins appears to relate to their ability to release calcium from intracellular stores through a receptor-mediated action. The receptor is intracellular, and appears to be G-protein coupled. The conversion of hepoxilin into its omega-hydroxy catabolite has recently been demonstrated through the action of an omega-hydroxylase. This enzyme is different from that which oxidizes leukotriene B4, as the former activity is lost when the cell is disrupted, while leukotriene B4-catabolic activity is recovered in both the intact and disrupted cell. Additionally, hepoxilin catabolism is inhibited by CCCP, a mitochondrial uncoupler, while leukotriene catabolism is unaffected. As hepoxilins cause the translocation of calcium from intracellular stores in the endoplasmic reticulum to the mitochondria, it is speculated that hepoxilin omega-oxidation takes place in the mitochondria, and the omega-oxidation product facilitates accumulation of the elevated cytosolic calcium by the mitochondria. (PMID 10692117, 11851887, 10086189).

   

hepoxilin B3

(5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoic acid

C20H32O4 (336.2300472)


A hepoxilin having (5Z,9E,14Z) double bond stereochemistry, a 10-hydroxy substituent and an (11S,12S)-epoxy group.

   

methyl 10-hydroxy-10-[3-(oct-2-en-1-yl)oxiran-2-yl]deca-5,8-dienoate

methyl 10-hydroxy-10-[3-(oct-2-en-1-yl)oxiran-2-yl]deca-5,8-dienoate

C21H34O4 (350.24569640000004)


   

methyl 10-hydroxy-10-[3-(octa-2,5-dien-1-yl)oxiran-2-yl]deca-5,8-dienoate

methyl 10-hydroxy-10-[3-(octa-2,5-dien-1-yl)oxiran-2-yl]deca-5,8-dienoate

C21H32O4 (348.2300472)


   

methyl (5z,8z,10r)-10-hydroxy-10-[(2s,3s)-3-[(2z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoate

methyl (5z,8z,10r)-10-hydroxy-10-[(2s,3s)-3-[(2z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoate

C21H34O4 (350.24569640000004)


   

methyl (5z,8z,10r)-10-hydroxy-10-[(2s,3s)-3-[(2z,5z)-octa-2,5-dien-1-yl]oxiran-2-yl]deca-5,8-dienoate

methyl (5z,8z,10r)-10-hydroxy-10-[(2s,3s)-3-[(2z,5z)-octa-2,5-dien-1-yl]oxiran-2-yl]deca-5,8-dienoate

C21H32O4 (348.2300472)


   

methyl (5z,8z,10s)-10-hydroxy-10-[(2s,3s)-3-[(2z,5z)-octa-2,5-dien-1-yl]oxiran-2-yl]deca-5,8-dienoate

methyl (5z,8z,10s)-10-hydroxy-10-[(2s,3s)-3-[(2z,5z)-octa-2,5-dien-1-yl]oxiran-2-yl]deca-5,8-dienoate

C21H32O4 (348.2300472)


   

(5z,8z,10r)-10-hydroxy-10-[(2s,3s)-3-[(2z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoic acid

(5z,8z,10r)-10-hydroxy-10-[(2s,3s)-3-[(2z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoic acid

C20H32O4 (336.2300472)


   

methyl (5z,8z,10s)-10-hydroxy-10-[(2s,3s)-3-[(2z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoate

methyl (5z,8z,10s)-10-hydroxy-10-[(2s,3s)-3-[(2z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,8-dienoate

C21H34O4 (350.24569640000004)


   

(5z,7s)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

(5z,7s)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

C20H32O4 (336.2300472)


   

(5z,7r)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

(5z,7r)-7-hydroxy-7-[(2s,3s)-3-[(2z,5z)-undeca-2,5-dien-1-yl]oxiran-2-yl]hept-5-enoic acid

C20H32O4 (336.2300472)